IFP Advisors, Inc - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 96 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q4 2017. The put-call ratio across all filers is 1.92 and the average weighting 0.5%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q2 2018$4,000
-20.0%
1500.0%0.00%
Q1 2018$5,0000.0%1500.0%0.00%
Q4 2017$5,0000.0%1500.0%0.00%
Q3 2017$5,000
+25.0%
1500.0%0.00%
Q2 2017$4,0000.0%1500.0%0.00%
Q1 2017$4,000
+33.3%
1500.0%0.00%
Q4 2016$3,000
-25.0%
1500.0%0.00%
Q3 2016$4,000
+100.0%
1500.0%0.00%
Q2 2016$2,000
-50.0%
1500.0%0.00%
Q4 2015$4,0001500.00%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q4 2017
NameSharesValueWeighting ↓
TANG KEVIN C 240,000$1,027,00095.09%
TANG CAPITAL MANAGEMENT LLC 10,049,224$43,011,0008.56%
RTW INVESTMENTS, LP 2,327,903$9,963,0000.15%
Boxer Capital, LLC 890,700$3,812,0000.13%
Tibra Equities Europe Ltd 72,600$311,0000.10%
WealthTrust Axiom LLC 25,400$108,0000.04%
GSA CAPITAL PARTNERS LLP 52,749$226,0000.02%
FIRST MIDWEST BANK TRUST DIVISION 34,231$147,0000.02%
HOLLENCREST CAPITAL MANAGEMENT 42,355$181,0000.02%
Summit Global Investments 48,500$208,0000.01%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders